Vehicle Platforms and Fuel Strategies of Car Manufacturers in India

Vehicle Platforms and Fuel Strategies of Car Manufacturers in India

15 Modular Platforms Anticipated to Account for 74.8% of the Total Market Production by FY 2023

RELEASE DATE
30-Mar-2017
REGION
South Asia, Middle East & North Africa
Research Code: P94D-01-00-00-00
SKU: AU01466-SA-MR_19861
$4,950.00
In stock
SKU
AU01466-SA-MR_19861
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This research service focuses on various modular platform and fuel strategies of car manufacturers including competitive analysis, technology proliferation, and key manufacturer profiling. Car manufacturers in India are currently investing in modular platform development to minimize costs, enhance customer value, and offset the cost impact of emission compliance. Investments of over 21,000 crores in new vehicle platforms are expected to result in a 30% decline in the number of platforms by 2023. Apart from direct material cost reduction through economies of scale, modular platforms are also expected to decrease the product development time and improve the model refresh cycles of car manufacturers. As a result, Frost & Sullivan anticipates that this reduction in product development time will also reduce the product lifecycles and thereby directly affect market dynamics. With regards to fuel strategies, Frost & Sullivan anticipates a decline of conventional powertrain technologies and a rapid adoption of mild hybrid powertrains. This is expected to be a key strategy of car manufacturers to meet emission requirements while facilitating the market demand for high fuel efficiency.

Table of Contents

Key Findings

Scope and Segmentation

Market Engineering Measurements

Trends for the CRO Market

Transformation of Industry Ecosystem

Pharmaceutical Outsourcing Value Chain

Transition from Small Molecules to Large Molecules

Biologics vs. Chemical Drugs

Key Technology Trends—BI Embedded in Clinical Trial Informatics on the Rise with Hybrid Business Models

Key Social Media Trend

Game-changing Companies

8 Big Market Themes for CROs

CEO’s Perspective

Key Companies to Watch

3 Big Predictions

Market Segmentation

Global R&D Spending—Pharmaceutical Drug Development

Global R&D Market Landscape

Global Market Perspective

CRO Product Development and Commercialization

Global CRO Market Snapshot

Global CRO Market Snapshot by Region

Global CRO Market Attractiveness Matrix

Global CRO Revenue by Clinical Development Stage

Market Segmentation—Percent Revenue by Clinical Development Stage

Market Segmentation—Percent Revenue Forecast by Therapeutic Area

Market Segmentation—Percent Revenue by Region

Global CRO Market—Key Trends and Impact on the Business

eClinical Solutions

eClinical Solutions—Applications and Technologies

Rise of Virtual Business Models

New Market Opportunities

Critical Unmet Needs and Game-changing Strategies

Global CRO Industry—Major Stake Holders

Global CRO Competitive Matrix

Merger, Acquisition, and Partnership Assessment

Global CRO Market Drivers

Global CRO Market Restraints

Market Engineering Measurements

Revenue Forecast

Percent Revenue Forecast by Region

Revenue Forecast by Region

Competitive Analysis—Market Share

Market Share Analysis

Competitive Environment

Competitive Analysis—Select Key Market Participants

Pre-clinical Trials Segment Overview

Market Engineering Measurements

Revenue Forecast

Pre-clinical Trials Segment Metrics Analysis

Pre-clinical Trials Segment Key Trends

North America Breakdown

Percent Revenue by Clinical Development Stage

Percent Share of Clinical Trials by Therapeutic Services

Percent Revenue by Therapeutic Area

Revenue by Clinical Development Stage

Market Engineering Measurements

Revenue Forecast

Percent Revenue Forecast by Clinical Development Stage

Pre-clinical and Phase I Trials Revenue Forecast

Phase II and Phase III Trials Revenue Forecast

Phase IV Trials and Pharmacovigilance Revenue Forecast

Biostatistics and Data Management Revenue Forecast

Bioanalytical and Central Laboratory Testing Revenue Forecast

HEOR Segment—Revenue Forecast

Market Share

3 Big Predictions

Legal Disclaimer

Market Engineering Methodology

Key Companies to Watch

Global CRO Market—Key Trends and Impact on the Business

List of Figures
  • 1. Total CRO Market: Market Snapshot by Region, Global, 2016–2021
  • 2. Total CRO Market: Game-changing Strategies, Global, 2016
  • 3. Total CRO Market: Competitive Matrix, Global, 2016
  • 4. Total CRO Market: Market Outlook, Global, 2016
  • 5. Total CRO Market: Key Market Drivers, Global, 2017–2021
  • 6. Total CRO Market: Key Market Restraints, Global, 2017–2021
  • 7. Total CRO Market: Market Engineering Measurements, Global, 2016
  • 8. Total CRO Market: Revenue Forecast by Region, Global, 2015–2021
  • 9. Total CRO Market: Competitive Structure, Global, 2016
  • 10. Total CRO Market: Competitive Analysis—Covance, Global, 2016
  • 11. Total CRO Market: Competitive Analysis—QuintilesIMS, Global, 2016
  • 12. Total CRO Market: Competitive Analysis—Charles River Laboratories, Global, 2016
  • 13. Total CRO Market: Competitive Analysis—PPD, Global, 2016
  • 14. Total CRO Market: Competitive Analysis—INC Research, Global, 2016
  • 15. Total CRO Market: Competitive Analysis—ICON plc, Global, 2016
  • 16. Total CRO Market: Competitive Analysis—PARAXEL International, Global, 2016
  • 17. Total CRO Market: Competitive Analysis—PRA Health Sciences, Global, 2016
  • 18. Total CRO Market: Competitive Analysis—inVentiv Health, Global, 2016
  • 19. Total CRO Market: Competitive Analysis—WuXi AppTec, Global, 2016
  • 20. Pre-clinical Trials Segment: Market Engineering Measurements, Global, 2016
  • 21. Phase I Trials Segment: Market Engineering Measurements, Global, 2016
  • 22. Phase II Trials Segment: Market Engineering Measurements, Global, 2016
  • 23. Phase III Trials Segment: Market Engineering Measurements, Global, 2016
  • 24. Phase IV Trials Segment: Market Engineering Measurements, Global, 2016
  • 25. Data Management Segment: Market Engineering Measurements, Global, 2016
  • 26. Biostatistics Segment: Market Engineering Measurements, Global, 2016
  • 27. Pharmacovigilance Segment: Market Engineering Measurements, Global, 2016
  • 28. HEOR Segment: Market Engineering Measurements, Global, 2016
  • 29. Central Laboratory Testing Segment: Market Engineering Measurements, Global, 2016
  • 30. Total CRO Market: Bioanalytical and cGMP Testing Segments, Global, 2016
  • 31. cGMP Testing Sub-segment: Market Engineering Measurements, Global, 2016
  • 32. Bioanalytical Testing Sub-segment: Market Engineering Measurements, Global, 2016
  • 33. Analytical Testing Services Segment: Company Market Share Analysis of Top 7 Participants, Global, 2015
  • 34. Analytical Testing Services Segment: Competitive Structure, Global, 2015
  • 35. Analytical Testing Services Segment: Competitive Analysis—Charles River Laboratories, Global, 2016
  • 36. Analytical Testing Services Segment: Competitive Analysis—Eurofins Scientific, Global, 2016
  • 37. Analytical Testing Services Segment: Competitive Analysis—SGS Life Sciences Services, Global, 2016
  • 38. Analytical Testing Services Segment: Competitive Analysis—PPD, Global, 2016
  • 39. Analytical Testing Services Segment: Competitive Analysis—BioReliance Corporation, Global, 2016
  • 40. Analytical Testing Services Segment: Competitive Analysis—Covance, Global, 2016
  • 41. CRO Market: Market Engineering Measurements, North America, 2016
  • 42. CRO Market: Market Engineering Measurements, Europe, 2016
  • 43. CRO Market: Market Engineering Measurements, APAC, 2016
  • 44. CRO Market: Market Engineering Measurements, ROW, 2016
List of Charts
  • 1. Total CRO Market: Market Engineering Measurements, Global, 2016
  • 2. Total CRO Market: Trends for the CRO Market, Global, 2016
  • 3. Total CRO Market: Game-changing Companies, Global, 2016
  • 4. Total CRO Market: Market Segmentation, Global, 2016
  • 5. Total CRO Market: R&D Spending, Global, 2015–2021
  • 6. Total CRO Market: R&D and Clinical Research Outsourcing Landscape, Global, 2016 and 2021
  • 7. Total CRO Market: Stages of Clinical Development, Global, 2016
  • 8. Total CRO Market: Market Attractiveness by Phase, Global, 2016
  • 9. Total CRO Market: Revenue by Clinical Development Stage, Global, 2016
  • 10. Total CRO Market: Percent Revenue by Clinical Development Stage, Global, 2016
  • 11. Total CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Global, 2016
  • 12. Total CRO Market: Percent Revenue by Therapeutic Area, Global, 2016
  • 13. Total CRO Market: Percent Revenue Forecast by Therapeutic Area, Global, 2021
  • 14. Total CRO Market: Percent Revenue by Region, Global, 2016
  • 15. Total CRO Market: Key Trends and Impact on Business, Global, 2016
  • 16. Total CRO Market: Revenue Forecast, Global, 2015–2021
  • 17. Total CRO Market: Percent Revenue Forecast by Region, Global, 2015–2021
  • 18. Total CRO Market: Percent Revenue by Participants, Global, 2015
  • 19. Pre-clinical Trials Segment: Revenue Forecast, Global, 2015–2021
  • 20. Pre-clinical Trials Segment: Metrics Analysis, Global, 2016
  • 21. Phase I Trials Segment: Revenue Forecast, Global, 2015–2021
  • 22. Phase I Trials Segment: Metrics Analysis, Global, 2016
  • 23. Phase II Trials Segment: Revenue Forecast, Global, 2015–2021
  • 24. Phase II Trials Segment: Metrics Analysis, Global, 2016
  • 25. Phase III Trials Segment: Revenue Forecast, Global, 2015–2021
  • 26. Phase III Trials Segment: Metrics Analysis, Global, 2016
  • 27. Phase IV Trials Segment: Revenue Forecast, Global, 2015–2021
  • 28. Phase IV trials Segment: Metrics Analysis, Global, 2016
  • 29. Data Management Segment: Revenue Forecast, Global, 2015–2021
  • 30. Data Management Segment: Metrics Analysis, Global, 2016
  • 31. Biostatistics Segment: Revenue Forecast, Global, 2015–2021
  • 32. Biostatistics Segment: Metrics Analysis, Global, 2016
  • 33. Pharmacovigilance Segment: Revenue Forecast, Global, 2015–2021
  • 34. Pharmacovigilance Segment: Metrics Analysis, Global, 2016
  • 35. HEOR Segment: Revenue Forecast, Global, 2015–2021
  • 36. HEOR Segment: Metrics Analysis, Global, 2016
  • 37. Central Laboratory Testing Segment: Revenue Forecast, Global, 2015–2021
  • 38. Central Laboratory Testing Segment: Metrics Analysis, Global, 2016
  • 39. Analytical Testing Services Segment: Overview, Global, 2016
  • 40. Analytical Testing Services Segment: Segmentation, Global, 2016
  • 41. Analytical Testing Services Segment: Percent Revenue by Sub-segment, Global, 2016
  • 42. cGMP Testing Sub-segment: Revenue Forecast, Global, 2015–2021
  • 43. cGMP Testing Sub-segment: Metrics Analysis, Global, 2016
  • 44. cGMP Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016
  • 45. Bioanalytical Testing Sub-segment: Revenue Forecast, Global, 2015–2021
  • 46. Bioanalytical Testing Sub-segment: Metrics Analysis, Global, 2016
  • 47. Bioanalytical Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016
  • 48. Analytical Testing Services Segment: Major Participants, Global, 2016
  • 49. Analytical Testing Services Segment: Percent Revenue by Participants, Global, 2015
  • 50. CRO Market: Percent Revenue by Clinical Development Stage, North America, 2016
  • 51. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, North America, 2016
  • 52. CRO Market: Percent Revenue by Therapeutic Area, North America, 2016
  • 53. CRO Market: Revenue by Clinical Development Stage, North America, 2016
  • 54. CRO Market: Revenue Forecast, North America, 2015–2021
  • 55. CRO Market: Percent Revenue Forecast by Clinical Development Stage, North America, 2015–2021
  • 56. Pre-clinical Trials Segment: Revenue Forecast, North America, 2015–2021
  • 57. Phase I Trials Segment: Revenue Forecast, North America, 2015–2021
  • 58. Phase II Trials Segment: Revenue Forecast, North America, 2015–2021
  • 59. Phase III Trials Segment: Revenue Forecast, North America, 2015–2021
  • 60. Phase IV Trials Segment: Revenue Forecast, North America, 2015–2021
  • 61. Pharmacovigilance Segment: Revenue Forecast, North America, 2015–2021
  • 62. Biostatistics Segment: Revenue Forecast, North America, 2015–2021
  • 63. Data Management Segment: Revenue Forecast, North America, 2015–2021
  • 64. Bioanalytical Testing Segment: Revenue Forecast, North America, 2015–2021
  • 65. Central Laboratory Testing Segment: Revenue Forecast, North America, 2015–2021
  • 66. HEOR Segment: Revenue Forecast, North America, 2015–2021
  • 67. CRO Market: Percent Revenue Breakdown, North America, 2015
  • 68. CRO Market: Percent Revenue by Clinical Development Stage, Europe, 2016
  • 69. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Europe, 2016
  • 70. CRO Market: Percent Revenue by Therapeutic Area, Europe, 2016
  • 71. CRO Market: Revenue by Clinical Development Stage, Europe, 2016
  • 72. CRO Market: Revenue Forecast, Europe, 2015–2021
  • 73. CRO Market: Percent Revenue Forecast by Clinical Development Stage, Europe, 2015–2021
  • 74. Pre-clinical Trials Segment: Revenue Forecast, Europe, 2015–2021
  • 75. Phase I Trials Segment: Revenue Forecast, Europe, 2015–2021
  • 76. Phase II Trials Segment: Revenue Forecast, Europe, 2015–2021
  • 77. Phase III Trials Segment: Revenue Forecast, Europe, 2015–2021
  • 78. Phase IV Trials Segment: Revenue Forecast, Europe, 2015–2021
  • 79. Pharmacovigilance Segment: Revenue Forecast, Europe, 2015–2021
  • 80. Biostatistics Segment: Revenue Forecast, Europe, 2015–2021
  • 81. Data Management Segment: Revenue Forecast, Europe, 2015–2021
  • 82. Bioanalytical Testing Segment: Revenue Forecast, Europe, 2015–2021
  • 83. Central Laboratory Testing Segment: Revenue Forecast, Europe, 2015–2021
  • 84. HEOR Segment: Revenue Forecast, Europe, 2015–2021
  • 85. CRO Market: Percent Revenue by Participants, Europe, 2015
  • 86. CRO Market: Percent Revenue by Clinical Development Stage, APAC, 2016
  • 87. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, APAC, 2016
  • 88. CRO Market: Percent Revenue by Therapeutic Area, APAC, 2016
  • 89. CRO Market: Revenue by Clinical Development Stage, APAC, 2016
  • 90. CRO Market: Revenue Forecast, APAC, 2015–2021
  • 91. CRO Market: Percent Revenue Forecast by Clinical Development Stage, APAC, 2015–2021
  • 92. Pre-clinical Trials Segment: Revenue Forecast, APAC, 2015–2021
  • 93. Phase I Trials Segment: Revenue Forecast, APAC, 2015–2021
  • 94. Phase II Trials Segment: Revenue Forecast, APAC, 2015–2021
  • 95. Phase III Trials Segment: Revenue Forecast, APAC, 2015–2021
  • 96. Phase IV Trials Segment: Revenue Forecast, APAC, 2015–2021
  • 97. Pharmacovigilance Segment: Revenue Forecast, APAC, 2015–2021
  • 98. Biostatistics Segment: Revenue Forecast, APAC, 2015–2021
  • 99. Data Management Segment: Revenue Forecast, APAC, 2015–2021
  • 100. Bioanalytical Testing Segment: Revenue Forecast, APAC, 2015–2021
  • 101. Central Laboratory Testing Segment: Revenue Forecast, APAC, 2015–2021
  • 102. HEOR Segment: Revenue Forecast, APAC, 2015–2021
  • 103. CRO Market: Percent Revenue by Participants, APAC, 2015
  • 104. CRO Market: Percent Revenue by Clinical Development Stage, ROW, 2016
  • 105. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, ROW, 2016
  • 106. CRO Market: Percent Revenue by Therapeutic Area, ROW, 2016
  • 107. CRO Market: Revenue by Clinical Development Stage, ROW, 2016
  • 108. CRO Market: Revenue Forecast, ROW, 2015–2021
  • 109. CRO Market: Percent Revenue Forecast by Clinical Development Stage, ROW, 2015–202
  • 110. Pre-clinical Trials Segment: Revenue Forecast, ROW, 2015–2021
  • 111. Phase I Trials Segment: Revenue Forecast, ROW, 2015–2021
  • 112. Phase II Trials Segment: Revenue Forecast, ROW, 2015–2021
  • 113. Phase III Trials Segment: Revenue Forecast, ROW, 2015–2021
  • 114. Phase IV Trials Segment: Revenue Forecast, ROW, 2015–2021
  • 115. Pharmacovigilance Segment: Revenue Forecast, ROW, 2015–2021
  • 116. Biostatistics Segment: Revenue Forecast, ROW, 2015–2021
  • 117. Data Management Segment: Revenue Forecast, ROW, 2015–2021
  • 118. Bioanalytical Testing Segment: Revenue Forecast, ROW, 2015–2021
  • 119. Central Laboratory Testing Segment: Revenue Forecast, ROW, 2015–2021
  • 120. HEOR Segment: Revenue Forecast, ROW, 2015–2021
  • 121. CRO Market: Percent Revenue Breakdown, ROW, 2015
Related Research
This research service focuses on various modular platform and fuel strategies of car manufacturers including competitive analysis, technology proliferation, and key manufacturer profiling. Car manufacturers in India are currently investing in modular platform development to minimize costs, enhance customer value, and offset the cost impact of emission compliance. Investments of over 21,000 crores in new vehicle platforms are expected to result in a 30% decline in the number of platforms by 2023. Apart from direct material cost reduction through economies of scale, modular platforms are also expected to decrease the product development time and improve the model refresh cycles of car manufacturers. As a result, Frost & Sullivan anticipates that this reduction in product development time will also reduce the product lifecycles and thereby directly affect market dynamics. With regards to fuel strategies, Frost & Sullivan anticipates a decline of conventional powertrain technologies and a rapid adoption of mild hybrid powertrains. This is expected to be a key strategy of car manufacturers to meet emission requirements while facilitating the market demand for high fuel efficiency.
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || Trends for the CRO Market~ || Transformation of Industry Ecosystem~ || Pharmaceutical Outsourcing Value Chain~ || Transition from Small Molecules to Large Molecules~ || Biologics vs. Chemical Drugs~ || Key Technology Trends—BI Embedded in Clinical Trial Informatics on the Rise with Hybrid Business Models~ || Key Social Media Trend~ || Game-changing Companies~ || 8 Big Market Themes for CROs~ || CEO’s Perspective~ || Key Companies to Watch~ || 3 Big Predictions~ | Market Overview~ || Market Segmentation~ || Global R&D Spending—Pharmaceutical Drug Development~ || Global R&D Market Landscape~ || Global Market Perspective~ || CRO Product Development and Commercialization~ || Global CRO Market Snapshot~ || Global CRO Market Snapshot by Region~ || Global CRO Market Attractiveness Matrix~ || Global CRO Revenue by Clinical Development Stage~ || Market Segmentation—Percent Revenue by Clinical Development Stage~ || Market Segmentation—Percent Revenue Forecast by Therapeutic Area~ || Market Segmentation—Percent Revenue by Region~ || Global CRO Market—Key Trends and Impact on the Business~ || eClinical Solutions~ || eClinical Solutions—Applications and Technologies~ || Rise of Virtual Business Models~ | Competitive Playbook~ || New Market Opportunities~ || Critical Unmet Needs and Game-changing Strategies~ || Global CRO Industry—Major Stake Holders~ || Global CRO Competitive Matrix~ || Merger, Acquisition, and Partnership Assessment~ | Drivers and Restraints—Total CRO Market~ || Global CRO Market Drivers~ || Global CRO Market Restraints~ | Forecasts and Trends—Total CRO Market~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Forecast by Region~ || Revenue Forecast by Region~ | Competitive Environment~ || Competitive Analysis—Market Share~ || Market Share Analysis~ || Competitive Environment~ || Competitive Analysis—Select Key Market Participants~ | CRO Segment Analysis—Pre-clinical Trials Segment~ || Pre-clinical Trials Segment Overview~ || Market Engineering Measurements~ || Revenue Forecast~ || Pre-clinical Trials Segment Metrics Analysis~ || Pre-clinical Trials Segment Key Trends~ | Phase I Trials Segment~ | Phase II Trials Segment~ | Phase III Trials Segment~ | Phase IV Trials Segment~ | Data Management Segment~ | Biostatistics Segment~ | Pharmacovigilance Segment~ | Health Economics and Outcomes Research (HEOR) Segment~ | Central Laboratory Testing Segment~ | Analytical Testing Service Segment~ | Analytical Testing Services—cGMP Testing Sub-segment~ | Analytical Testing Services—Bioanalytical Testing Sub-segment~ | Analytical Testing Services Segment—Competitive Environment~ | North America CRO Market Overview~ || North America Breakdown~ || Percent Revenue by Clinical Development Stage~ || Percent Share of Clinical Trials by Therapeutic Services~ || Percent Revenue by Therapeutic Area~ || Revenue by Clinical Development Stage~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Forecast by Clinical Development Stage~ | North America Segment Analysis by Clinical Development Stage~ || Pre-clinical and Phase I Trials Revenue Forecast~ || Phase II and Phase III Trials Revenue Forecast~ || Phase IV Trials and Pharmacovigilance Revenue Forecast~ || Biostatistics and Data Management Revenue Forecast~ || Bioanalytical and Central Laboratory Testing Revenue Forecast~ || HEOR Segment—Revenue Forecast~ || Market Share~ | Europe CRO Market Overview~ | Europe Segment Analysis by Clinical Development Stage~ | APAC CRO Market Overview~ | APAC Segment Analysis by Clinical Development Stage~ | ROW CRO Market Overview~ | ROW Segment Analysis by Clinical Development Stage~ | Growth Opportunities for the Global CRO Market~ | The Last Word~ || 3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || Key Companies to Watch~ || Global CRO Market—Key Trends and Impact on the Business~
List of Charts and Figures 1. Total CRO Market: Market Snapshot by Region, Global, 2016–2021~ 2. Total CRO Market: Game-changing Strategies, Global, 2016~ 3. Total CRO Market: Competitive Matrix, Global, 2016~ 4. Total CRO Market: Market Outlook, Global, 2016~ 5. Total CRO Market: Key Market Drivers, Global, 2017–2021~ 6. Total CRO Market: Key Market Restraints, Global, 2017–2021~ 7. Total CRO Market: Market Engineering Measurements, Global, 2016~ 8. Total CRO Market: Revenue Forecast by Region, Global, 2015–2021~ 9. Total CRO Market: Competitive Structure, Global, 2016~ 10. Total CRO Market: Competitive Analysis—Covance, Global, 2016~ 11. Total CRO Market: Competitive Analysis—QuintilesIMS, Global, 2016~ 12. Total CRO Market: Competitive Analysis—Charles River Laboratories, Global, 2016~ 13. Total CRO Market: Competitive Analysis—PPD, Global, 2016~ 14. Total CRO Market: Competitive Analysis—INC Research, Global, 2016~ 15. Total CRO Market: Competitive Analysis—ICON plc, Global, 2016~ 16. Total CRO Market: Competitive Analysis—PARAXEL International, Global, 2016~ 17. Total CRO Market: Competitive Analysis—PRA Health Sciences, Global, 2016~ 18. Total CRO Market: Competitive Analysis—inVentiv Health, Global, 2016~ 19. Total CRO Market: Competitive Analysis—WuXi AppTec, Global, 2016~ 20. Pre-clinical Trials Segment: Market Engineering Measurements, Global, 2016~ 21. Phase I Trials Segment: Market Engineering Measurements, Global, 2016~ 22. Phase II Trials Segment: Market Engineering Measurements, Global, 2016~ 23. Phase III Trials Segment: Market Engineering Measurements, Global, 2016~ 24. Phase IV Trials Segment: Market Engineering Measurements, Global, 2016~ 25. Data Management Segment: Market Engineering Measurements, Global, 2016~ 26. Biostatistics Segment: Market Engineering Measurements, Global, 2016~ 27. Pharmacovigilance Segment: Market Engineering Measurements, Global, 2016~ 28. HEOR Segment: Market Engineering Measurements, Global, 2016~ 29. Central Laboratory Testing Segment: Market Engineering Measurements, Global, 2016~ 30. Total CRO Market: Bioanalytical and cGMP Testing Segments, Global, 2016~ 31. cGMP Testing Sub-segment: Market Engineering Measurements, Global, 2016~ 32. Bioanalytical Testing Sub-segment: Market Engineering Measurements, Global, 2016~ 33. Analytical Testing Services Segment: Company Market Share Analysis of Top 7 Participants, Global, 2015~ 34. Analytical Testing Services Segment: Competitive Structure, Global, 2015~ 35. Analytical Testing Services Segment: Competitive Analysis—Charles River Laboratories, Global, 2016~ 36. Analytical Testing Services Segment: Competitive Analysis—Eurofins Scientific, Global, 2016~ 37. Analytical Testing Services Segment: Competitive Analysis—SGS Life Sciences Services, Global, 2016~ 38. Analytical Testing Services Segment: Competitive Analysis—PPD, Global, 2016~ 39. Analytical Testing Services Segment: Competitive Analysis—BioReliance Corporation, Global, 2016~ 40. Analytical Testing Services Segment: Competitive Analysis—Covance, Global, 2016~ 41. CRO Market: Market Engineering Measurements, North America, 2016~ 42. CRO Market: Market Engineering Measurements, Europe, 2016~ 43. CRO Market: Market Engineering Measurements, APAC, 2016~ 44. CRO Market: Market Engineering Measurements, ROW, 2016~| 1. Total CRO Market: Market Engineering Measurements, Global, 2016~ 2. Total CRO Market: Trends for the CRO Market, Global, 2016~ 3. Total CRO Market: Game-changing Companies, Global, 2016~ 4. Total CRO Market: Market Segmentation, Global, 2016~ 5. Total CRO Market: R&D Spending, Global, 2015–2021~ 6. Total CRO Market: R&D and Clinical Research Outsourcing Landscape, Global, 2016 and 2021~ 7. Total CRO Market: Stages of Clinical Development, Global, 2016~ 8. Total CRO Market: Market Attractiveness by Phase, Global, 2016 ~ 9. Total CRO Market: Revenue by Clinical Development Stage, Global, 2016~ 10. Total CRO Market: Percent Revenue by Clinical Development Stage, Global, 2016~ 11. Total CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Global, 2016~ 12. Total CRO Market: Percent Revenue by Therapeutic Area, Global, 2016~ 13. Total CRO Market: Percent Revenue Forecast by Therapeutic Area, Global, 2021~ 14. Total CRO Market: Percent Revenue by Region, Global, 2016~ 15. Total CRO Market: Key Trends and Impact on Business, Global, 2016~ 16. Total CRO Market: Revenue Forecast, Global, 2015–2021~ 17. Total CRO Market: Percent Revenue Forecast by Region, Global, 2015–2021~ 18. Total CRO Market: Percent Revenue by Participants, Global, 2015~ 19. Pre-clinical Trials Segment: Revenue Forecast, Global, 2015–2021~ 20. Pre-clinical Trials Segment: Metrics Analysis, Global, 2016~ 21. Phase I Trials Segment: Revenue Forecast, Global, 2015–2021~ 22. Phase I Trials Segment: Metrics Analysis, Global, 2016~ 23. Phase II Trials Segment: Revenue Forecast, Global, 2015–2021~ 24. Phase II Trials Segment: Metrics Analysis, Global, 2016~ 25. Phase III Trials Segment: Revenue Forecast, Global, 2015–2021~ 26. Phase III Trials Segment: Metrics Analysis, Global, 2016~ 27. Phase IV Trials Segment: Revenue Forecast, Global, 2015–2021~ 28. Phase IV trials Segment: Metrics Analysis, Global, 2016~ 29. Data Management Segment: Revenue Forecast, Global, 2015–2021~ 30. Data Management Segment: Metrics Analysis, Global, 2016~ 31. Biostatistics Segment: Revenue Forecast, Global, 2015–2021~ 32. Biostatistics Segment: Metrics Analysis, Global, 2016~ 33. Pharmacovigilance Segment: Revenue Forecast, Global, 2015–2021~ 34. Pharmacovigilance Segment: Metrics Analysis, Global, 2016~ 35. HEOR Segment: Revenue Forecast, Global, 2015–2021~ 36. HEOR Segment: Metrics Analysis, Global, 2016~ 37. Central Laboratory Testing Segment: Revenue Forecast, Global, 2015–2021~ 38. Central Laboratory Testing Segment: Metrics Analysis, Global, 2016~ 39. Analytical Testing Services Segment: Overview, Global, 2016~ 40. Analytical Testing Services Segment: Segmentation, Global, 2016~ 41. Analytical Testing Services Segment: Percent Revenue by Sub-segment, Global, 2016~ 42. cGMP Testing Sub-segment: Revenue Forecast, Global, 2015–2021~ 43. cGMP Testing Sub-segment: Metrics Analysis, Global, 2016~ 44. cGMP Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016~ 45. Bioanalytical Testing Sub-segment: Revenue Forecast, Global, 2015–2021~ 46. Bioanalytical Testing Sub-segment: Metrics Analysis, Global, 2016~ 47. Bioanalytical Testing Sub-segment: Percent Revenue by Type of Service, Global, 2016~ 48. Analytical Testing Services Segment: Major Participants, Global, 2016~ 49. Analytical Testing Services Segment: Percent Revenue by Participants, Global, 2015~ 50. CRO Market: Percent Revenue by Clinical Development Stage, North America, 2016~ 51. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, North America, 2016~ 52. CRO Market: Percent Revenue by Therapeutic Area, North America, 2016~ 53. CRO Market: Revenue by Clinical Development Stage, North America, 2016~ 54. CRO Market: Revenue Forecast, North America, 2015–2021~ 55. CRO Market: Percent Revenue Forecast by Clinical Development Stage, North America, 2015–2021~ 56. Pre-clinical Trials Segment: Revenue Forecast, North America, 2015–2021~ 57. Phase I Trials Segment: Revenue Forecast, North America, 2015–2021~ 58. Phase II Trials Segment: Revenue Forecast, North America, 2015–2021~ 59. Phase III Trials Segment: Revenue Forecast, North America, 2015–2021~ 60. Phase IV Trials Segment: Revenue Forecast, North America, 2015–2021~ 61. Pharmacovigilance Segment: Revenue Forecast, North America, 2015–2021~ 62. Biostatistics Segment: Revenue Forecast, North America, 2015–2021~ 63. Data Management Segment: Revenue Forecast, North America, 2015–2021~ 64. Bioanalytical Testing Segment: Revenue Forecast, North America, 2015–2021~ 65. Central Laboratory Testing Segment: Revenue Forecast, North America, 2015–2021~ 66. HEOR Segment: Revenue Forecast, North America, 2015–2021~ 67. CRO Market: Percent Revenue Breakdown, North America, 2015~ 68. CRO Market: Percent Revenue by Clinical Development Stage, Europe, 2016~ 69. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, Europe, 2016~ 70. CRO Market: Percent Revenue by Therapeutic Area, Europe, 2016~ 71. CRO Market: Revenue by Clinical Development Stage, Europe, 2016~ 72. CRO Market: Revenue Forecast, Europe, 2015–2021~ 73. CRO Market: Percent Revenue Forecast by Clinical Development Stage, Europe, 2015–2021~ 74. Pre-clinical Trials Segment: Revenue Forecast, Europe, 2015–2021~ 75. Phase I Trials Segment: Revenue Forecast, Europe, 2015–2021~ 76. Phase II Trials Segment: Revenue Forecast, Europe, 2015–2021~ 77. Phase III Trials Segment: Revenue Forecast, Europe, 2015–2021~ 78. Phase IV Trials Segment: Revenue Forecast, Europe, 2015–2021~ 79. Pharmacovigilance Segment: Revenue Forecast, Europe, 2015–2021~ 80. Biostatistics Segment: Revenue Forecast, Europe, 2015–2021~ 81. Data Management Segment: Revenue Forecast, Europe, 2015–2021~ 82. Bioanalytical Testing Segment: Revenue Forecast, Europe, 2015–2021~ 83. Central Laboratory Testing Segment: Revenue Forecast, Europe, 2015–2021~ 84. HEOR Segment: Revenue Forecast, Europe, 2015–2021~ 85. CRO Market: Percent Revenue by Participants, Europe, 2015~ 86. CRO Market: Percent Revenue by Clinical Development Stage, APAC, 2016~ 87. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, APAC, 2016~ 88. CRO Market: Percent Revenue by Therapeutic Area, APAC, 2016~ 89. CRO Market: Revenue by Clinical Development Stage, APAC, 2016~ 90. CRO Market: Revenue Forecast, APAC, 2015–2021~ 91. CRO Market: Percent Revenue Forecast by Clinical Development Stage, APAC, 2015–2021~ 92. Pre-clinical Trials Segment: Revenue Forecast, APAC, 2015–2021~ 93. Phase I Trials Segment: Revenue Forecast, APAC, 2015–2021~ 94. Phase II Trials Segment: Revenue Forecast, APAC, 2015–2021~ 95. Phase III Trials Segment: Revenue Forecast, APAC, 2015–2021~ 96. Phase IV Trials Segment: Revenue Forecast, APAC, 2015–2021~ 97. Pharmacovigilance Segment: Revenue Forecast, APAC, 2015–2021~ 98. Biostatistics Segment: Revenue Forecast, APAC, 2015–2021~ 99. Data Management Segment: Revenue Forecast, APAC, 2015–2021~ 100. Bioanalytical Testing Segment: Revenue Forecast, APAC, 2015–2021~ 101. Central Laboratory Testing Segment: Revenue Forecast, APAC, 2015–2021~ 102. HEOR Segment: Revenue Forecast, APAC, 2015–2021~ 103. CRO Market: Percent Revenue by Participants, APAC, 2015~ 104. CRO Market: Percent Revenue by Clinical Development Stage, ROW, 2016~ 105. CRO Market: Percent Share of Clinical Trials by Therapeutic Services, ROW, 2016~ 106. CRO Market: Percent Revenue by Therapeutic Area, ROW, 2016~ 107. CRO Market: Revenue by Clinical Development Stage, ROW, 2016~ 108. CRO Market: Revenue Forecast, ROW, 2015–2021~ 109. CRO Market: Percent Revenue Forecast by Clinical Development Stage, ROW, 2015–202~ 110. Pre-clinical Trials Segment: Revenue Forecast, ROW, 2015–2021~ 111. Phase I Trials Segment: Revenue Forecast, ROW, 2015–2021~ 112. Phase II Trials Segment: Revenue Forecast, ROW, 2015–2021~ 113. Phase III Trials Segment: Revenue Forecast, ROW, 2015–2021~ 114. Phase IV Trials Segment: Revenue Forecast, ROW, 2015–2021~ 115. Pharmacovigilance Segment: Revenue Forecast, ROW, 2015–2021~ 116. Biostatistics Segment: Revenue Forecast, ROW, 2015–2021~ 117. Data Management Segment: Revenue Forecast, ROW, 2015–2021~ 118. Bioanalytical Testing Segment: Revenue Forecast, ROW, 2015–2021~ 119. Central Laboratory Testing Segment: Revenue Forecast, ROW, 2015–2021~ 120. HEOR Segment: Revenue Forecast, ROW, 2015–2021~ 121. CRO Market: Percent Revenue Breakdown, ROW, 2015~
Author Sistla Raghuvamsi
Industries Automotive
WIP Number P94D-01-00-00-00
Is Prebook No